ConCallIQ
Go Pro
HIMADRISPECIALITYCHEMICA Manufacturing 23 Apr 2026

Himadri Speciality Chemical Ltd — Q4 FY26

Himadri delivered a record Q4 FY26 with consolidated revenue of ₹1,288 crore (+14% YoY), EBITDA of ₹280 crore (+21% YoY), and PAT of ₹208 crore (+34% YoY), driven by strong execution in specialty carbon black and coal tar pitch.

bullish high
Compare with...
Revenue ₹1,288 Cr +14%
EBITDA ₹280 Cr +21%
PAT ₹208 Cr +34%
EBITDA Margin 21.7% +130bps
Duration 59 min
Read Time 1 min read

✓ Verified against BSE filing

2-Minute Summary

✦ AI-Generated from Full Transcript

Himadri delivered a record Q4 FY26 with consolidated revenue of ₹1,288 crore (+14% YoY), EBITDA of ₹280 crore (+21% YoY), and PAT of ₹208 crore (+34% YoY), driven by strong execution in specialty carbon black and coal tar pitch. The company commissioned a 70,000 MTPA specialty carbon black facility, debottlenecked coal tar distillation to 600,000 MTPA, and commenced anode material production (200 MTPA) in April 2026. Management guided for PAT doubling to ₹1,100+ crore by FY28 and expects both top-line and bottom-line growth in FY27. The LFP cathode project (40,000 MTPA) is on track with first 2,000 MTPA by Q3 FY27. Bila Tires contributed ₹187 crore revenue and targets ₹3,000 crore in four years. Key risk: forex volatility from unhedged positions could impact near-term profitability.

Risks4 trackedTranscriptfull text
Research workspace

Focused Modules

!Risks 4 risks

Risk Intelligence

Forex volatility from unhedged positions

View Risks →
Transcript Full text

Call Transcript

Full transcript text is available on this route.

Read Transcript →

Quarter Snapshot

Specialty carbon black capacity 130,000 MTPA
+117% YoY

Total carbon black capacity now 250,000 MTPA; world's largest single-location specialty carbon black plant.

Coal tar distillation capacity 600,000 MTPA
+20% YoY

Debottlenecked from 500,000 MTPA; supports growth and export via new terminals.

Bila Tires revenue ₹187 crore
N/A (first full year)

First half-year of operations; targeting ₹3,000 crore in 4 years.

R&D spend ₹120 crore
N/A

FY26 spend; team of 180+ scientists including 28 PhDs driving innovation.

Fast read

Guidance and risk preview

Top guidance PAT to double to ₹1,100+ crore by FY28

Management committed to doubling FY25 PAT of ₹555 crore to over ₹1,100 crore by FY28.

Top risk Forex volatility from unhedged positions

Sharp rupee depreciation led to hedging losses in Q4; management keeps positions open due to import-export parity, but volatility could impact earn...

View Risks →